Response to pre-radiation chemotherapy as a predictor of survival in patients with newly diagnosed malignant astrocytoma: A north central cancer treatment group (NCCTG) study

被引：0
|
作者：
Jaeckle, K
Ballman, K
O'Fallon, J
Scheithauer, B
Giannini, C
Moynihan, T
Buckner, J
机构：
[1] Mayo Clin, Jacksonville, FL USA
[2] Mayo Clin, Rochester, MN USA
来源：
NEURO-ONCOLOGY | 2004年 / 6卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：376 / 376
页数：1
相关论文
共 50 条
  • [21] Which Treatment Outcomes Should be Addressed in the Pre-Radiation Consultation With Rectal Cancer Patients? A Delphi Consensus Study Among Patients and Radiation Oncologists
    Kunneman, Marleen
    Pieterse, Arwen H.
    Stiggelbout, Anne M.
    Marijnen, Corrie A. M.
    PSYCHO-ONCOLOGY, 2013, 22 : 8 - 8
  • [22] CORRELATION OF UGT 1A1*28 MUTATIONS WITH OUTCOME AND TOXICITY IN NEWLY DIAGNOSED GBM PATIENTS TREATED WITH RADIOTHERAPY, IRINOTECAN, AND CARMUSTINE ON N997D, A PHASE II NORTH CENTRAL CANCER TREATMENT GROUP (NCCTG) STUDY
    Jaeckle, Kurt
    Ballman, Karla
    Felten, Sara
    Ames, Matthew
    Buckner, Jan
    NEURO-ONCOLOGY, 2008, 10 (05) : 844 - 844
  • [23] North Central cancer treatment group (NCCTG) N0432: phase II trial of docetaxel with capecitabine and bevacizumab as first line chemotherapy for patients with metastatic breast cancer.
    Perez, E. A.
    Hillman, D. W.
    Kugler, J. W.
    Steen, P. D.
    Fitch, T. R.
    Rowland, K. M.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S104 - S104
  • [24] N997D: Pilot trial of CPT11 during RT followed by CPT11 and BCNU in newly diagnosed gliablastoma (GBM) patients: A North Central Cancer Group (NCCTG) Study
    Jaeckle, KA
    Ballman, KV
    Schomberg, P
    Uhm, J
    Schiethauer, B
    Giannini, C
    Felton, S
    Brown, P
    Jan, BC
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 117S - 117S
  • [25] PS-341 and gemcitabine in patients with metastatic pancreatic adenocarcinoma (ACA): A North Central Cancer Treatment Group (NCCTG) randomized phase II study
    Alberts, Steven R.
    Gill, Sharlene
    Foster, Nathan
    Morton, Roscoe
    Kugier, John
    Schaefer, Paul
    Sargent, Daniel
    ANNALS OF ONCOLOGY, 2004, 15 : 240 - 241
  • [26] North Central Cancer Treatment Group (NCCTG) N0432: phase II trial of docetaxel with capecitabine and bevacizumab as first-line chemotherapy for patients with metastatic breast cancer
    Perez, E. A.
    Hillman, D. W.
    Dentchev, T.
    Le-Lindqwister, N. A.
    Geeraerts, L. H.
    Fitch, T. R.
    Liu, H.
    Graham, D. L.
    Kahanic, S. P.
    Gross, H. M.
    Patel, T. A.
    Palmieri, F. M.
    Dueck, A. C.
    ANNALS OF ONCOLOGY, 2010, 21 (02) : 269 - 274
  • [27] What is the added value of actual tumor measurements (TM) in predicting overall survival (OS)? The North Central Cancer Treatment Group (NCCTG) findings
    Campbell, M. E.
    Mandrekar, S. J.
    Hillman, S. L.
    Goldberg, R. M.
    Adjei, A. A.
    Pitot, H. C.
    Rowland, K. M.
    Grothey, A.
    Buckner, J. C.
    Sargent, D. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [28] Phase II study of high-dose chemotherapy before radiation in children with newly diagnosed high-grade astrocytoma - Final analysis of Children's Cancer Group study 9933
    MacDonald, TJ
    Arenson, EB
    Ater, J
    Sposto, R
    Bevan, HE
    Bruner, J
    Deutsch, M
    Kurczynski, E
    Luerssen, T
    McGuire-Cullen, P
    O'Brien, R
    Shah, N
    Steinbok, P
    Strain, J
    Thomson, J
    Holmes, E
    Vezina, G
    Yates, A
    Phillips, P
    Packer, R
    CANCER, 2005, 104 (12) : 2862 - 2871
  • [29] Combined High-dose Radiation Therapy and Systemic Chemotherapy Improves Survival in Patients With Newly Diagnosed Metastatic Nasopharyngeal Cancer
    Lin, Shaojun
    Tham, Ivan W. K.
    Pan, Jianji
    Han, Lu
    Chen, Qisong
    Lu, Jiade J.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2012, 35 (05): : 474 - 479
  • [30] CPT-11 for bile-duct and gallbladder carcinomaA phase II north central cancer treatment group (NCCTG) study
    Steven R. Alberts
    Paul A. Fishkin
    Lawrence J. Burgart
    Peter J. Cera
    Michelle R. Mahoney
    Roscoe F. Morton
    Patricia A. Johnson
    Suresh Nair
    Richard M. Goldberg
    International Journal of Gastrointestinal Cancer, 2002, 32 : 107 - 114
12345